Healthcare - Biotechnology - NASDAQ - US
$ 11.48
-5.67 %
$ 571 M
Market Cap
-4.16
P/E
Price Target
Average
161.32%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--0.10%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mineralys Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for MLYS of $30 , with forecasts ranging from a low of $30 to a high of $30 .
MLYS Lowest Price Target
Wall Street Target
30 USD
161.32%
MLYS Average Price Target
Wall Street Target
30 USD
161.32%
MLYS Highest Price Target
Wall Street Target
30 USD
161.32%
REVENUE FORECAST
Revenue Forecast Chart MLYS
EBIT FORECAST
EBIT Forecast Chart MLYS
NET INCOME FORECAST
Net Income Chart MLYS